| Ind-Swift Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532305 |
NSE Symbol : INDSWFTLAB |
P/E(TTM) : 5.99 |
|
ISIN Demat : INE915B01019 |
Div & Yield% : - |
EPS(TTM) : 18.06 |
|
Book Value(₹) : 170.51 |
Market Cap(₹Cr) : 638.85 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 2.71 | 30.46 | 381.73 | 276.28 | 270.30 | 299.01 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2.71 | 30.46 | 381.73 | 276.28 | 270.30 | 299.01 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 12.95 | 11.14 | 411.84 | 7.11 | 7.40 | 5.55 |
| Total Income | 15.65 | 41.60 | 793.57 | 283.40 | 277.70 | 304.56 |
| Total Expenditure | 14.71 | 34.99 | 309.22 | 222.04 | 206.90 | 239.19 |
| PBIDT | 0.95 | 6.61 | 484.35 | 61.36 | 70.80 | 65.37 |
| Interest | 0.41 | 0.17 | -11.48 | 21.05 | 21.14 | 20.38 |
| PBDT | 0.54 | 6.44 | 495.83 | 40.30 | 49.66 | 44.98 |
| Depreciation | 0.22 | 0.25 | 12.67 | 13.56 | 13.19 | 13.89 |
| Tax | 0.00 | 0.00 | 144.41 | 5.09 | 6.38 | 14.05 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | -10.84 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.32 | 6.19 | 349.59 | 21.65 | 30.10 | 17.05 |
| Extra-ordinary Items | 0.00 | 0.00 | 271.04 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.32 | 6.19 | 78.55 | 21.65 | 30.10 | 17.05 |
| EPS (Unit Curr.) | 0.05 | 1.05 | 59.17 | 3.66 | 5.09 | 2.89 |
| EPS (Adj) (Unit Curr.) | 0.05 | 1.05 | 59.17 | 3.66 | 5.09 | 2.89 |
| Calculated EPS (Unit Curr.) | 0.05 | 1.05 | 59.17 | 3.66 | 5.09 | 2.89 |
| Calculated EPS (Adj) (Unit Curr.) | 0.05 | 1.05 | 59.17 | 3.66 | 5.09 | 2.89 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.22 | 4.19 | 236.66 | 14.66 | 20.37 | 11.54 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.22 | 4.19 | 236.66 | 14.66 | 20.37 | 11.54 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 59.09 | 59.09 | 59.09 | 59.09 | 59.09 | 59.09 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 449.18 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 35.06 | 21.70 | 126.88 | 22.21 | 26.19 | 21.86 |
| PBDTM(%) | 19.93 | 21.14 | 129.89 | 14.59 | 18.37 | 15.04 |
| PATM(%) | 11.81 | 20.32 | 91.58 | 7.84 | 11.14 | 5.70 |